Searching the Resource Information Network

Our searching services are busy right now. Please try again later

  • Register
X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X

Leaving Community

Are you sure you want to leave this community? Leaving the community will revoke any permissions you have been granted in this community.

No
Yes

Rapid monocyte kinetics in acute myocardial infarction are sustained by extramedullary monocytopoiesis.

Florian Leuschner | Philipp J Rauch | Takuya Ueno | Rostic Gorbatov | Brett Marinelli | Won Woo Lee | Partha Dutta | Ying Wei | Clinton Robbins | Yoshiko Iwamoto | Brena Sena | Aleksey Chudnovskiy | Peter Panizzi | Edmund Keliher | John M Higgins | Peter Libby | Michael A Moskowitz | Mikael J Pittet | Filip K Swirski | Ralph Weissleder | Matthias Nahrendorf
The Journal of experimental medicine | 2012

Monocytes (Mo) and macrophages (MΦ) are emerging therapeutic targets in malignant, cardiovascular, and autoimmune disorders. Targeting of Mo/MΦ and their effector functions without compromising innate immunity's critical defense mechanisms first requires addressing gaps in knowledge about the life cycle of these cells. Here we studied the source, tissue kinetics, and clearance of Mo/MΦ in murine myocardial infarction, a model of acute inflammation after ischemic injury. We found that a) Mo tissue residence time was surprisingly short (20 h); b) Mo recruitment rates were consistently high even days after initiation of inflammation; c) the sustained need of newly made Mo was fostered by extramedullary monocytopoiesis in the spleen; d) splenic monocytopoiesis was regulated by IL-1β; and e) the balance of cell recruitment and local death shifted during resolution of inflammation. Depending on the experimental approach, we measured a 24 h Mo/MΦ exit rate from infarct tissue between 5 and 13% of the tissue cell population. Exited cells were most numerous in the blood, liver, and spleen. Abrogation of extramedullary monocytopoiesis proved deleterious for infarct healing and accelerated the evolution of heart failure. We also detected rapid Mo kinetics in mice with stroke. These findings expand our knowledge of Mo/MΦ flux in acute inflammation and provide the groundwork for novel anti-inflammatory strategies for treating heart failure.

Pubmed ID: 22213805

Research resources used in this publication

None found

Antibodies used in this publication

None found

Associated grants

  • Agency: NHLBI NIH HHS, United States
    Id: R01 HL095612
  • Agency: NCI NIH HHS, United States
    Id: R24 CA092782
  • Agency: NHLBI NIH HHS, United States
    Id: U01 HL080731
  • Agency: NHLBI NIH HHS, United States
    Id: HHSN268201000044C
  • Agency: NHLBI NIH HHS, United States
    Id: R01 HL096576
  • Agency: NCI NIH HHS, United States
    Id: R24-CA92782
  • Agency: NHLBI NIH HHS, United States
    Id: R01 HL095629
  • Agency: NHLBI NIH HHS, United States
    Id: UO1-HL080731
  • Agency: NIAID NIH HHS, United States
    Id: R01 AI084880
  • Agency: NHLBI NIH HHS, United States
    Id: R01HL095629
  • Agency: NHLBI NIH HHS, United States
    Id: R01HL096576

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

This is a list of tools and resources that we have found mentioned in this publication.


C57BL/6J (tool)

RRID:IMSR_JAX:000664

Mus musculus with name C57BL/6J from IMSR.

View all literature mentions

B6.SJL-Ptprca Pepc/BoyJ (tool)

RRID:IMSR_JAX:002014

Mus musculus with name B6.SJL-Ptprca Pepc/BoyJ from IMSR.

View all literature mentions

B6.129S7-Il1r1tm1Imx/J (tool)

RRID:IMSR_JAX:003245

Mus musculus with name B6.129S7-Il1r1tm1Imx/J from IMSR.

View all literature mentions